Novus signs agreement with biotech firm
Novus International, Inc. announced a worldwide agreement today with emerging
biotechnology company BioResource International, Inc (BRI). The signed agreement
states that Novus will be the exclusive worldwide marketer for BRI's patented
"We are pleased to enter into this partnership with Novus International to
bring value through improved feed efficiency solutions to the global
market," stated Dr. Giles Shih, Co-founder and President of BioResource
International, Inc. "Novus brings strong customer relationships, technical
expertise in all areas of animal production, and a wide ranging global reach
that complement BRI's strengths in the area of biotechnology development and
BRI's enzymes provide animal producers with an excellent
source of versatile and pellet stable enzymes that allow them to achieve
improved animal performance and greater flexibility in dietary formulations.
"Novus is excited about bringing this technology into our CIBENZA feed additive
enzyme portfolio. It represents a strong strategic fit for our overall
portfolio and is aligned with our drive to bring advanced feed technologies to
the market," stated Giovanni Gasperoni, Executive Vice President, Marketing and
BioResource International, Inc.
Click here to subscribe to the free AllAboutFeed
To comment, login here
Or register to be able to comment.